Assessment of Interstitial Inflammation 150
Interstitial inflammation was assessed by immunohistochemical (IHC) staining for 151 macrophages (CD68) and lymphocytes (CD3) using paraffin-embedded kidney sections. 152
The number of CD68+ cells or CD3+ cells in the outer medulla were counted from five 153 different fields for each sample and averaged. The inflammatory cytokines, tumor-necrosis 154 factor α (TNFα) and transforming growth factor β 1 (TGF-β 1 ) were quantified by western 155
blot. 156

Immunohistochemistry and Immunofluorescent Staining 157
Paraffin sections (4 μm) were blocked in blocking buffer for 30 min at room 158 temperature and incubated with anti-αSMA (Dako, Carpinteria, CA), anti-CD68 (Abcam, 159 Cambridge, MA), anti-CD3 (Dako, Carpinteria, CA) overnight at 4 o C. Secondary antibodies 160
were HRP-conjugated anti-mouse IgG (Dako, Carpinteria, CA) or HRP-conjugated anti-161 rabbit IgG (Vector, Burlingame, CA) for 30 min at room temperature. Slides were developed 162 with the DAB substrate kit (Vector, Burlingame, CA) and covered with Cytoseal XYL 163 mounting medium. Frozen OCT blocks were cut into 8 μm sections, fixed in acetone for 5 164 min at room temperature and incubated with anti-CD31 (BD, Franklin Lakes, NJ) overnight 165 at 4 o C, and then treated with Alexa Fluor-488-conjugated anti-mouse IgG (Invitrogen, 9 Eugene, OR) for 30 min at room temperature, and covered with VECTASHIELD Mounting 167
Medium with DAPI (Vector, Burlingame, CA). 168
Western Blot for VEGF, eNOS, TNFα and TGFβ 1 169
Tissue homogenates were prepared according to lysis protocol for radioimmunoprecipitation 170 assay buffer (Santa Cruz Biotechnology, Santa Cruz, CA). Kidney homogenates (35 μg) were 171 suspended in loading buffer and subjected to a 12% sodium dodecyl sulfate polyacrylamide gel 172 electrophoresis. The resolved proteins were transferred to an Immun-Blot PVDF membrane 173 (Bio-Rad, Hercules, CA). After electroblotting, the membrane was incubated overnight with 174
anti-TNFα or anti-TGFβ 1 (Novus, Littleton, CO), anti-VEGF or anti-eNOS (Santa Cruz 175
Biotechnology, Santa Cruz, CA) antibodies. Membranes were further incubated for 1 hour with 176 HRP-conjugated polyclonal rabbit anti-goat IgG or monoclonal goat anti-mouse IgG (Pierce, 177
Rockford, IL). Protein bands were detected with an enhanced chemiluminescence detection 178 system (Cell Signaling, Danvers, MA) and autoradiography. Bands were evaluated for integrated 179 density values on Image Lab™ Software (Bio-Rad, Hercules, CA). 180
Statistical Analysis 181
All results are expressed as means ± SEM. Statistical analyses were carried out using Prism 182 software (GraphPad Software, Inc., San Diego, CA). Multiple group comparisons were 183 performed using ANOVA followed by a Tukey post hoc test. Figure 1A ) that were identified as swollen mitochondria with 196 loss of cristae membranes when examined at 30,000x magnification ( Figure 1B ). Figure 1C  197 shows swollen mitochondria in a capillary endothelial cell and a degenerating interstitial 198 cell that also contained swollen mitochondria. Within 5 min of reperfusion, some 199 endothelial cells show early signs of detachment from the basement membrane, while 200 others show clear degenerative changes ( Figure 1D ). Endothelial cell detachment damaged 201 capillary integrity and led to interstitial edema and extravasation of red blood cells into the 202 interstitial space ( Figure 1E ). Aggregates of platelets were observed in many peritubular 203 capillaries with some completely blocking the capillary lumen even after 5 min reperfusion, 204 resulting in stasis of red blood cells and "no-reflow" in the kidney ( Figure 1F) . 205
SS-31 Protects Endothelial Cells during IR and Mitigates Capillary Damage 206
Endothelial cells from SS-31 treated animals did not show ischemic injury even after 45 207 min ischemia (Figure 2A ). The endothelial cells remained attached to the basement 208 membrane with cytoplasmic processes extending along the capillary wall ( Figure 2B ). The 209 mitochondrion identified in the cytoplasm was examined under 80,000x magnification and 210 revealed intact inner and outer mitochondrial membranes and stacks of cristae membranes 211 ( Figure 2C ). Figure 2D shows the cytoplasmic processes of the endothelial cell extending 212 around the capillary wall, and the highlighted area revealed normal mitochondria when 213 examined under 30,000x magnification ( Figure 2E ). Within 5 min of reperfusion, blood 214 flow was restored and the endothelial cell remained attached to the basement membrane 215 ( Figure 2F ). Platelet aggregation was not seen in the SS-31 treated samples. 216
SS-31 minimizes medullary tubular cell swelling and red blood cell trapping 217
The medullary thick ascending limb (mTAL) is particularly susceptible to ischemic 218 injury because of the low oxygen tension in the outer medulla and the high metabolic 219 demands required for solute reabsorption (16). Cells of the mTAL have been shown to 220 undergo mitochondrial swelling with ischemia and subsequently progress to cell death by 221 apoptosis or necrosis (7, 41) . Using electron microscopy, we found dramatic cell swelling in 222 mTAL segments following 45 min ischemia ( Figure 3A) . The mitochondria were rounded 223 and empty, with few cristae membranes ( Figure 3B ). They also appear very disorganized 224 because of the loss of basal membrane invaginations. In contrast, the medullary tubular 225 cells in animals treated with SS-31 were not swollen ( Figure 3C ). The mitochondria were 226 elongated and surrounded by basal membrane invaginations, and cristae membranes were 227 well-preserved even after 45 min of complete ischemia ( Figure 3D ). Because tubular cell swelling was prevented in the SS-31 animals, the lack of red cell 233 trapping resulted in improved capillary blood flow (Figure 4) . 234
Renal Microvascular Rarefaction 4 weeks after Ischemic Injury 235
Renal ischemia can result in permanent damage to peritubular capillaries, with the 236 outer medulla being the most affected (2, 23, 46) . A 30-40% loss of microvascular density 237 has been reported 4 weeks after ischemic insult (30). We examined the long-term effects of 238 acute ischemia on peritubular capillaries by immunohistochemical staining for CD31, a 239 biomarker for endothelial cells. Quantitative image analyses show that there was a 240 dramatic reduction in CD31 staining 4 weeks after ischemia when compared to the sham 241 group ( Figure 5A ). CD31 staining was improved almost 4-fold in the SS-31 treated kidneys. 242
We also examined the glomerular capillaries because a previous study using intravital 243 videomicroscopy showed that glomerular capillary blood flow is also reduced following 244 ischemia (49). The dramatic loss of glomerular capillaries 4 weeks after ischemia was 245 improved 10-fold by acute administration of SS-31 during IR injury ( Figure 5B ). Ischemia 246 can also cause a loss of cortical arterioles (52). We examined the number of cortical 247 arterioles by immunostaining for α-smooth muscle actin (α-SMA). Figure 5C shows that 248 SS-31 significantly reduced the loss of cortical arterioles 4 weeks after IR injury. The loss of 249 endothelial cells after acute ischemia is reflected in the significant decrease in eNOS 250 expression in the saline group, and this was significantly improved by pretreatment with 251 13 SS-31 ( Figure 5D ). Continuous treatment with SS-31 after ischemia did not provide any 252 further protection of endothelial cells. 253
Loss of microvasculature after acute ischemic injury results in chronic tissue hypoxia, 254 and it is well-known that hypoxia will stimulate the release of proangiogenic factors such 255 as vascular endothelial growth factor (VEGF) (9). At 4 weeks after ischemic insult, we 256 found a >10-fold increase in VEGF expression in the saline-treated kidneys and this was 257 significantly reduced by SS-31 treatment ( Figure 5E ). Continuous treatment with SS-31 for 258 4 weeks did not result in any further change in VEGF expression. 259
Recovery of Renal Function after Acute Ischemia 260
We examined serum creatinine and BUN at weekly intervals up to four weeks after IR 261 injury (n=7 in each group). In the saline-treated group, two rats died within 48 hours after 262 ischemia. All animals that received SS-31, even only during the immediate IR period, 263 survived at least four weeks after ischemia. Renal function for the surviving animals are 264 summarized in Table 1 . Serum creatinine and BUN were within normal limits in both 265 groups within one week after ischemia, and there was no significant difference between the 266 two groups thereafter. Renal function was not determined in the pump group that received 267 SS-31 continuously after ischemia as the saline-treated animals had normal renal function 268 at 4 weeks. 269
Renal Histopathology 4 weeks after `Ischemic Injury 270
Despite the recovery of renal function within one week after acute IR injury, 271 histopathology revealed chronic changes in the kidneys of saline-treated animals. 
SS-31 reduces Interstitial Inflammation 4 weeks after Ischemia 278
Inflammation plays an important role in the initiation and extension of AKI. Acute 279 ischemic injury is associated with interstitial inflammation, with infiltration of 280 macrophages and neutrophils (48). Tumor-necrosis factor-α (TNF-α) is the most potent 281 mediator of inflammation, and it is upregulated and released after ischemia (42). We found 282 a significant upregulation of TNF-α in kidney tissues even 4 weeks after ischemia ( 
Tubulointerstitial Fibrosis 4 weeks after Ischemia 289
The tubulointerstitial influx of inflammatory cells contribute to fibrosis by releasing 290 profibrotic cytokines (29) . TGFβ is considered the key mediator of renal fibrosis (19, 43) , 291 and its expression was upregulated 2.5-fold 4 weeks after IR injury, and this was 292 completely abolished by treatment with SS-31 during the immediate IR period ( Figure 8A Hypoxia is a potent stimulus of inflammation and interstitial macrophage numbers and 338 chronic damage were found to correlate with capillary density in human chronic kidney 339 disease (24). We found a 23-fold increase in TNFα expression at 4 weeks after ischemia, 340 and 8-fold increase in infiltrating macrophages and lymphocytes. All of these inflammatory 341 markers were significantly reduced by SS-31 treatment. The tubulointerstitial influx of 342 inflammatory cells contribute to fibrosis by releasing profibrotic cytokines including TGF-343 β1, a multifunctional cytokine that regulates cellular proliferation and extracellular matrix 344 production (35, 36, 42, 43) . In this study, a 2.5-fold increase in TGF-β1 expression was 345 associated with a significant increase in αSMA+ myefibroblasts and collagen deposition in 346 the interstitium at 4 weeks. By minimizing chronic inflammation, SS-31 completely blocked 347 the upregulation of TGF-β1 and mitigated fibrotic changes at 4 weeks. Besides preventing 348 fibrosis, inhibition of TGF-β1 expression also helps to minimize tubular atrophy and 349 promote angiogenesis (33). The loss of cristae membranes results from cardiolipin peroxidation that has been 364 reported to occur during ischemia (31, 32, 38) . Cardiolipin is a phospholipid that is 365 exclusively expressed on the inner mitochondrial membrane and is required for proper 366 cristae formation and for stabilization of respiratory chain supercomplexes for more 367 efficient electron transfer (27, 37, 39, 51) . We recently reported that SS-31 selectively 368 binds to cardiolipin via electrostatic and hydrophobic interactions (6). By interacting with 369 cardiolipin, SS-31 prevents cardiolipin from converting cytochrome c into a peroxidase 370 while protecting its electron carrying function (4, 5). As a result, SS-31 protects 371 mitochondrial cristae structure to allow rapid restoration of ATP levels for cell survival. 372
Our results show that SS-31 is highly effective against the multifactorial phenomenon of IR 373 injury by protecting mitochondria of all cell types involved. 374
Chronic kidney disease affects 8% of the United States population and frequently 375 progresses to organ failure and cardiovascular death. Yet there are no effective therapies 376 for renal fibrosis. Current drug development efforts have largely focused on inhibiting 377 inflammatory and fibrotic pathways (18). Endothelial protection has recently been 378 suggested as a novel therapeutic target for mitigating the progression of AKI to CKD (20) . 379
Transplantation of endothelial progenitor cells has been attempted in animal models but 380 they failed to engraft in medullary blood vessels (13). To the best of our knowledge, SS-31 381 is the first agent that has been shown to protect endothelial cells from ischemic injury, 382 prevent "no-reflow", and reduce microvascular rarefaction, interstitial inflammation and 383 fibrosis. Interestingly, continuous treatment with SS-31 over the 4 weeks did not provide 384 further protection, suggesting that protecting the microvasculature from acute ischemic 385 injury is sufficient to block downstream tissue remodeling. Our results suggest that SS-31 386 may be beneficial in minimizing the risk of progression to chronic kidney disease following 387 acute ischemic injury. Based on its mechanism of action, SS-31 is best suited for clinical 388 situations where renal ischemia is anticipated, such as transplantation, shock, and major 389 surgery such as coronary artery bypass graft surgery and aortic aneurysm repair. SS-31 390 may be helpful in improving graft survival in renal transplantation as IR injury is a major cause 391 of delayed graft function and chronic graft dysfunction (15, 36 
